Fusion Pharmaceuticals Inc. Annual Operating Lease, Payments in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Fusion Pharmaceuticals Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2021 to 2023.
  • Fusion Pharmaceuticals Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $973K, a 123% increase year-over-year.
  • Fusion Pharmaceuticals Inc. annual Operating Lease, Payments for 2023 was $6.59M, a 350% increase from 2022.
  • Fusion Pharmaceuticals Inc. annual Operating Lease, Payments for 2022 was $1.47M, a 27.9% increase from 2021.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.59M +$5.13M +350% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-20
2022 $1.47M +$320K +27.9% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-16
2021 $1.15M Jan 1, 2021 Dec 31, 2021 10-K 2022-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.